These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38952277)

  • 1. Isolation of camel single domain antibodies against Yersinia pestis V270 antigen based on a semi-synthetic single domain antibody library and development of a VHH-based lateral flow assay.
    Wang B; Wang C; Li B; Yang J; Lin P; Jin X; Niu Y; Zhang W; Zhang X; Huang Y
    Vet Med Sci; 2024 Jul; 10(4):e1532. PubMed ID: 38952277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis.
    Lillo AM; Ayriss JE; Shou Y; Graves SW; Bradbury AR; Pavlik P
    PLoS One; 2011; 6(12):e27756. PubMed ID: 22174746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis.
    Hau D; Wade B; Lovejoy C; Pandit SG; Reed DE; DeMers HL; Green HR; Hannah EE; McLarty ME; Creek CJ; Chokapirat C; Arias-Umana J; Cecchini GF; Nualnoi T; Gates-Hollingsworth MA; Thorkildson PN; Pflughoeft KJ; AuCoin DP
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010287. PubMed ID: 35320275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples.
    Hsu HL; Chuang CC; Liang CC; Chiao DJ; Wu HL; Wu YP; Lin FP; Shyu RH
    BMC Infect Dis; 2018 Aug; 18(1):402. PubMed ID: 30107826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
    Philipovskiy AV; Cowan C; Wulff-Strobel CR; Burnett SH; Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2005 Mar; 73(3):1532-42. PubMed ID: 15731051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples.
    Gomes-Solecki MJ; Savitt AG; Rowehl R; Glass JD; Bliska JB; Dattwyler RJ
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):339-46. PubMed ID: 15699431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV.
    Ivanov MI; Hill J; Bliska JB
    Clin Vaccine Immunol; 2014 May; 21(5):667-73. PubMed ID: 24599533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and property study of the recombinant Camel anti-SpaA-N single domain antibodies].
    Lu QX; Qing GL; Yang CJ; Xia XQ; Li JW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):55-8. PubMed ID: 22230504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Comparison between Large and Mini Vertical Flow Immunoassay Platforms for
    Devadhasan JP; Gu J; Chen P; Smith S; Thomas B; Gates-Hollingsworth M; Hau D; Pandit S; AuCoin D; Zenhausern F
    Anal Chem; 2021 Jul; 93(27):9337-9344. PubMed ID: 33989499
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
    Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
    Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific determination of influenza H7N2 virus based on biotinylated single-domain antibody from a phage-displayed library.
    Gong X; Zhu M; Li G; Lu X; Wan Y
    Anal Biochem; 2016 May; 500():66-72. PubMed ID: 26450565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Yersinia pestis and its antibody response in great gerbils (Rhombomys opimus) by subcutaneous infection.
    Zhang Y; Dai X; Wang X; Maituohuti A; Cui Y; Rehemu A; Wang Q; Meng W; Luo T; Guo R; Li B; Abudurexiti A; Song Y; Yang R; Cao H
    PLoS One; 2012; 7(10):e46820. PubMed ID: 23071647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an up-converting phosphor technology-based 10-channel lateral flow assay for profiling antibodies against Yersinia pestis.
    Hong W; Huang L; Wang H; Qu J; Guo Z; Xie C; Zhu Z; Zhang Y; Du Z; Yan Y; Zheng Y; Huang H; Yang R; Zhou L
    J Microbiol Methods; 2010 Nov; 83(2):133-40. PubMed ID: 20801166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
    Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Protective Antiplague Immune Responses by Self-Adjuvanting Bionanoparticles Derived from Engineered Yersinia pestis.
    Wang X; Singh AK; Zhang X; Sun W
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32152195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor.
    Qiu L; Feng Y; Ma X; Li J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):513-519. PubMed ID: 28475681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.
    Sofer-Podesta C; Ang J; Hackett NR; Senina S; Perlin D; Crystal RG; Boyer JL
    Infect Immun; 2009 Apr; 77(4):1561-8. PubMed ID: 19124600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.
    Dormeshkin D; Shapira M; Karputs A; Kavaleuski A; Kuzminski I; Stepanova E; Gilep A
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5093-5103. PubMed ID: 35723693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.